File:Taxol.svg · Wikimedia Commons · See Wikimedia Commons
paclitaxel
Sign in to saveAlso known as BMS-181339-01, PAX, taxol, 5beta,20-epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine, taxol A
Paclitaxel, sold under the brand name Taxol among others, is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. It is administered by intravenous injection. There is also an albumin-bound formulation.
OverviewAI-generated
Paclitaxel is a chemical compound with the formula C₄₇H₅₁NO₁₄. Its mass is listed as 853.331, while its weight is recorded as 853.9. The compound carries a charge of 0 and has a stylized name written as PACLitaxel.
Chemical properties include an xlogp value of 2.5 and a topological polar surface area of 221. The molecule contains 4 hydrogen bond donors and 14 hydrogen bond acceptors. It is identified by the InChIKey RCINICONZNJXQF-MZXODVADSA-N and the PubChem CID 36314.
In academic literature, paclitaxel is the subject of 51,627 PubMed entries. The compound is also referenced by 1,066 other encyclopedia articles and has a dedicated category on Commons.
Synthesized by Vinony from 15 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Drug.StdInChI
- 1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
- Drug.StdInChIKey
- RCINICONZNJXQF-MZXODVADSA-N
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 458461737
- Drug.image
- Taxol.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- Paclitaxel-from-hydrate-xtal-Mercury-3D-sk.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Taxol, Abraxane, others
- Drug.MedlinePlus
- a607070
- Drug.DailyMedID
- Paclitaxel
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- Intravenous
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- CD01
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
via Wikipedia infobox
Chemical data
- Formula
- C47H51NO14
- Molecular weight
- 853.9 g/mol
- IUPAC name
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
- InChIKey
- RCINICONZNJXQF-MZXODVADSA-N
- XLogP
- 2.5
- Polar surface area
- 221 Ų
- H-bond donors
- 4
- H-bond acceptors
- 14
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1992
- Admin. routes
- parenteral
- Indications
- breast carcinoma, gastric adenocarcinoma, gastric carcinoma, melanoma
via ChEMBL · EBI
Research
51,627 papers- nab-Paclitaxel mechanisms of action and delivery.Journal of controlled release : official journal of the Controlled Release Society · 2013
- Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer.Biomolecules · 2019
- Progress in research on paclitaxel and tumor immunotherapy.Cellular & molecular biology letters · 2019
- Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.British journal of cancer · 1993
- Post-genomic illumination of paclitaxel biosynthesis.Nature plants · 2024
via PubMed
Wikidata facts
- Mass
- 853.331
- Manufacturer
- Pfizer
Show 11 more facts
- chemical formula
- C₄₇H₅₁NO₁₄
- World Health Organisation international non-proprietary name
- paclitaxel
- medical condition treated
- squamous cell carcinoma of the lung
- isomeric SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
- canonical SMILES
- CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
- Commons category
- Paclitaxel
- subject has role
- essential medicine
- stylized name
- PACLitaxel
- significant drug interaction
- phenytoin
- legal status (medicine)
- boxed warning
- has characteristic
- natural product
Sources (11)
via Wikidata · CC0
~31 min read
Encyclopedic overview
22 sectionsContents
- Medical use
- Similar compounds
- Restenosis
- Side effects
- Mechanism of action
- Chemistry
- Production
- Bark processing
- Semisynthesis
- Biosynthesis
- Total synthesis
- History
- Plant screening program
- Early clinical trials, supply and the transfer to BMS
- Society and culture
- Legal status
- Economics
- Research
- Additional images
- References
- Bibliography
- External links
{{Infobox drug | Verifiedfields = changed | verifiedrevid = 458461737 | image = Taxol.svg | image_class = skin-invert-image | width = 250 | alt = | caption = | image2 = Paclitaxel-from-hydrate-xtal-Mercury-3D-sk.png | image_class2 = bg-transparent | alt2 = | pronounce = | tradename = Taxol, Abraxane, others | Drugs.com = | MedlinePlus = a607070 | DailyMedID = Paclitaxel | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Intravenous | class = | ATC_prefix = L01 | ATC_suffix = CD01 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = Rx-only | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status =
| bioavailability = 6.5% (by mouth) | protein_bound = 89 to 98% | metabolism = Liver (CYP2C8 and CYP3A4) | metabolites = | onset = | elimination_half-life = 5.8 hours | duration_of_action = | excretion = Oral administration Fecal: 76% ± 21%
Excerpted from Wikipedia’s “paclitaxel” article, available under the CC BY-SA 4.0 licence.